According to UC Irvine researchers, defects in cell-surface sugars may advance short-term inflammation and long-term neurodegeneration in the central nervous systems of multiple sclerosis (MS) patients.
These findings, published online in the Journal of Biological Chemistry, imply that oral therapy may be possible through a dietary supplement resembling glucosamine, an over-the-counter product associated with arthritis relief.
Currently, there is no known cure for multiple sclerosis, a neurodegenerative disease. There are two stages to the disease, beginning with inflammation and demyelination
Privacy Disclaimer: After submitting content for publication the New University, in print or online, contributors relinquish the right to remove or alter contributions as they appear in publication. Contributors also give their ownership rights to the New University.
Site Usage and Copyright: All articles, staff photos and other content on our website are copyrighted by the New University. By viewing our website, you agree not to reproduce or republish our content without express written permission.
